Red Vascular Technologies

Red Vascular Technologies is a private, pre-revenue medical device innovator targeting the challenging market of complex aortic aneurysms. Its core technology is a non-modular, branched endoprosthesis delivered via a single access site, aiming to replace the current standard of complex modular and fenestrated grafts. Founded by seasoned medical device inventors with a track record of commercial success, the company is in the development stage, seeking to translate its simplified design into clinical use with the potential for safer, more efficient procedures.

Patented platform for designing and manufacturing a one-piece, non-modular, branched endograft with continuous fabric, delivered via a single femoral access site. It aims to eliminate fenestrations, junctional endoleaks, and graft migration associated with current modular systems.

Competes against large medical device companies (e.g., Cook Medical, Gore, Medtronic) offering complex fenestrated and branched modular endografts, which are the current standard of care. Also faces potential competition from other startups developing next-generation solutions for complex aortic repair.